Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Cardiac Electrophysiology
What is your step-wise approach to differentiating SVT with aberrancy versus VT?
Related Questions
What are your preferred methods for QTc calculation for normal, tachycardic and bradycardic heart rates?
Would you pursue imaging to clear the left atrial appendage or have a risk/benefit discussion with a patient prior to semi-urgent cardioversion if there was concern for delayed administration or a single missed dose of anticoagulation?
How do you manage patients with atrial fibrillation having a thromboembolic infarct despite being on adequate anticoagulation?
What is the most updated consensus regarding the use of pill in the pocket oral anticoagulation in paroxysmal atrial fibrillation, and populations of patients who are most likely to be considered for enrollment in clinical trials?
What clinical parameters or CV imaging considerations would prompt you to consider AV nodal ablation for patients with cardiac amyloidosis and symptomatic atrial fibrillation?
When do you favor using cardiac CT compared to TEE for outpatient surveillance in the immediate post-Watchman period?
What would be a reasonable threshold to recommend epicardial CRT-D intra-op in a patient post-ACS with LVEF< 35%, QRS duration > 120, and breakthrough VT undergoing emergent CABG?
What sheath(s) is preferred for crossing a bioprosthetic aortic valve during VT ablation?
With the rise in home monitoring devices, how should we approach asymptomatic NSVT detected in healthy individuals with no prior cardiac history and with low risk cardiac profile?
How do you approach agitation management, especially the use of neuroleptics in hospitalized patients with a prolonged QTc?
